UroGen Pharma Ltd. (URGN)
Nasdaq • URGN • IL0011407140
28.74Last close
Market Closed
Nasdaq • URGN • IL0011407140
UroGen Pharma Ltd. (Nasdaq: URGN) has a market capitalization of $1.4B. Last close $28.74 (as of 2026-11-05); 52-week range $16.50 to $50.81. ORTEX data as of 2026-11-03: short interest is 12.17% of free float, 4.4 days to cover and the average cost to borrow is 0.43%.